Try our Advanced Search for more refined results
United States of America v. Regeneron Pharmaceuticals, Inc.
Case Number:
1:20-cv-11217
Court:
Nature of Suit:
Other Statutes: False Claims Act
Judge:
Firms
Companies
Sectors & Industries:
-
October 07, 2020
Regeneron Says Feds' Kickback Theory Makes Charity Illegal
Regeneron Pharmaceuticals on Wednesday pressed a judge to dismiss claims it shelled out kickbacks to get doctors to prescribe its injectable eye disease drug through a co-pay foundation, arguing the federal government's legal theory would render virtually all charitable payments illegal.
-
September 22, 2020
Feds Slam Regeneron's Attempt To Duck Kickback Suit
The federal government has urged a Massachusetts federal judge not to toss its suit accusing Regeneron Pharmaceuticals of paying illegal kickbacks to get doctors to prescribe its injectable eye disease drug, arguing that the biotechnology company is using a "legally irrelevant" argument.
-
August 24, 2020
Regeneron Says Feds' Kickback Suit 'Defies Common Sense'
Federal prosecutors in Massachusetts can't prevail in their suit accusing Regeneron Pharmaceuticals of paying tens of millions of dollars in illegal kickbacks through a foundation to get doctors to prescribe its injectable eye disease drug, the biotechnology company has told a federal judge.
-
June 24, 2020
Regeneron Paid Kickbacks To Boost Eye Drug, Feds Say
Federal prosecutors in Massachusetts accused New York pharmaceutical company Regeneron Pharmaceuticals on Wednesday of paying tens of millions of dollars in illegal kickbacks through a foundation to get doctors to prescribe its injectable eye disease drug.
- ← Previous
- 1
- 2
- Next →